Silo Pharma (SILO) EPS (Weighted Average and Diluted) (2017 - 2025)
Historic EPS (Weighted Average and Diluted) for Silo Pharma (SILO) over the last 9 years, with Q3 2025 value amounting to -$0.12.
- Silo Pharma's EPS (Weighted Average and Diluted) rose 4545.45% to -$0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.95, marking a year-over-year increase of 2016.81%. This contributed to the annual value of -$1.19 for FY2024, which is 53.41% up from last year.
- As of Q3 2025, Silo Pharma's EPS (Weighted Average and Diluted) stood at -$0.12, which was up 4545.45% from -$0.19 recorded in Q2 2025.
- Silo Pharma's 5-year EPS (Weighted Average and Diluted) high stood at $3.2 for Q3 2021, and its period low was -$0.58 during Q4 2022.
- Over the past 5 years, Silo Pharma's median EPS (Weighted Average and Diluted) value was -$0.31 (recorded in 2022), while the average stood at -$0.12.
- Per our database at Business Quant, Silo Pharma's EPS (Weighted Average and Diluted) surged by 3210000.0% in 2021 and then plummeted by 681853.6% in 2022.
- Over the past 5 years, Silo Pharma's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.47 in 2021, then decreased by 23.4% to -$0.58 in 2022, then soared by 34.48% to -$0.38 in 2023, then fell by 23.74% to -$0.47 in 2024, then soared by 74.48% to -$0.12 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.12 for Q3 2025, versus -$0.19 for Q2 2025 and -$0.23 for Q1 2025.